Merck’s Covid-19 Pill Shows Promise Against Omicron
[ad_1] Merck cited six preclinical studies performed by researchers outside the company. The examples include research published this week in the New England Journal of Medicine that found molnupiravir among several Covid-19 antiviral drugs that “may show efficacy for treating patients infected with the Omicron variant.” Molnupiravir, which was cleared for use in the U.S. […]
Continue Reading